CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Price, Forecast & Analysis
Europe - FRA:AFX - DE0005313704 - Common Stock
AFX.DE Key Statistics, Chart & Performance
The current stock price of AFX.DE is 42.9 EUR. In the past month the price decreased by -6.99%. In the past year, price decreased by -25.44%.
AFX.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.4 | 106.23B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.43 | 49.49B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.21 | 23.86B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.38 | 24.10B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.9 | 23.43B | ||
| BIM.PA | BIOMERIEUX | 27.84 | 12.72B | ||
| DIA.MI | DIASORIN SPA | 16.98 | 3.30B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.62 | 1.29B | ||
| DRW8.DE | DRAEGERWERK AG | 9.36 | 1.13B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 27.73 | 1.04B | ||
| ELN.MI | EL.EN. SPA | 16.98 | 872.10M | ||
| GVS.MI | GVS SPA | 48.67 | 828.61M |
Related stock screener links
About AFX.DE
Company Profile
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,730 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
Company Info
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5730
Phone: 493641220331
CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ
What does AFX do?
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,730 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
Can you provide the latest stock price for CARL ZEISS MEDITEC AG - BR?
The current stock price of AFX.DE is 42.9 EUR. The price decreased by -1.65% in the last trading session.
What is the dividend status of CARL ZEISS MEDITEC AG - BR?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.44%. The yearly dividend amount is currently 1.11.
How is the ChartMill rating for CARL ZEISS MEDITEC AG - BR?
AFX.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is CARL ZEISS MEDITEC AG - BR (AFX.DE) expected to grow?
The Revenue of CARL ZEISS MEDITEC AG - BR (AFX.DE) is expected to grow by 6.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is CARL ZEISS MEDITEC AG - BR worth?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 3.84B EUR. This makes AFX.DE a Mid Cap stock.
AFX.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AFX.DE. When comparing the yearly performance of all stocks, AFX.DE is a bad performer in the overall market: 89.68% of all stocks are doing better.
AFX.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. Both the profitability and the financial health of AFX.DE get a neutral evaluation. Nothing too spectacular is happening here.
AFX.DE Financial Highlights
Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.71. The EPS decreased by -25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.19% | ||
| ROA | 4.49% | ||
| ROE | 7.51% | ||
| Debt/Equity | 0.27 |
AFX.DE Forecast & Estimates
22 analysts have analysed AFX.DE and the average price target is 55.56 EUR. This implies a price increase of 29.5% is expected in the next year compared to the current price of 42.9.
For the next year, analysts expect an EPS growth of -13.79% and a revenue growth 6.32% for AFX.DE